Navigating the complexities of today’s disclosure demands can be tedious and time consuming.

New regulations in the EU and UK along with tightened scrutiny from the FDA means sponsors have to put new processes in place to stay on top of disclosure requirements. TrialScope Disclose has been supporting the Industry to implement transparency best practices for nearly 20 years. From advisory services when setting up your study to protocol registration, final results postings and plain language summaries, we can support you every step of the way.

Download your free materials:

“Your Keys to Understanding EU Transparency"

Understand the new plain-language summary (PLS) requirements needed for the European Medicines Agency’s Clinical Trials Information System (CTIS)/Clinical Trials Regulation (CTR) and changes to the UK’s disclosure and transparency requirements. Your free, four-chapter eBook from Pink Sheet provides a look at the latest changes impacting the industry today.

“Plain Language Summaries (PLS): Key Considerations, from CTIS to Content Accessibility”

Plain-language summaries (PLS) are now required as part of clinical trial results submission to the EU’s CTIS. Explore the elements of successful PLS, including necessary elements for clinical trials data, considerations for reviewers, and more.

“Clinical Trial Transparency Policy: The Reference Guide”

Compliance in trial disclosure and transparency doesn’t come easy. Worldwide, over 90 countries require the public disclosure of clinical trials data on 30+ trial registries, each with their own data mandates and evolving disclosure requirements. TrialScope Disclose has gathered a collection of these key requirements for easy reference.